EPD FAQ

A 50% reduction in medications have been suggested by the study group, on the average. Many of the conditions appeared to be responding at a rate above 90%.

Dr. Leonard McEwen began work on the method in the mid-1960’s in London. He continued the work of the late Dr. S. Popper, who had noted that hay fever symptoms were reduced as a side effect of treatments he was doing on nasal polyps using injections of hyaluronidase. Dr McEwen identified the active ingredients and he and others have since worked to refine the EPD techniques and determine the best patterns for making the treatment effective. Dr. W. A. “Butch” Shrader, Jr. is the United States counterpart in recent years.  Dr. Shrader recovered from disability via the use of EPD and became interested in what it had to offer for other patients.

Over 50 disorders have been shown to respond to EPD. It has been used to treat all aspects of allergies including allergens in the inhalant, food, and chemical realms.  Because having increased T-cells actively doing their thing benefits us in many ways, patients with many co-existing conditions have also improved, sometimes dramatically.  EPD has been seen to have a favourable impact on conditions including:

* Hay Fever,
* Chronic Rhinitis,
* Food Allergy/Intolerance,
* Food Preservatives/Additives Sensitivity,
* Fatigue,
* Migraine and other Headaches,
* Candida,
* Chemical Sensitivity/MCS,
* Chronic Sinusitis,
* Asthma,
* Ear Infections,
* Depression,
* Eczema (Dermatitis),
* Arthritis,
* Rheumatoid Arthritis,
* Chronic Bronchitis,


* Colitis,
* Muscle Pain,
* Joint Pain,
* Migraine Headaches,
* Hyperactivity/ADD (Attention Deficit Disorder),
* Emotional Problems,
* Behavioral Problems,
* Facial Angioedema (swelling of face or lips),
* Anaphylactic Reactions (life threatening swelling),
* Severe/Chronic Urticaria (Hives),
* Nasal Polyps,
* Crohn’s Disease,
* Irritable Bowel Syndrome,
* Ulcerative Colitis,
* Epilepsy,
* Post-Viral Syndrome,
* ME, CFIDS, CFS (Chronic Fatigue Syndrome),
* Autism,
* Contact Dermatitis,
* Psychological reactions to foods,
* Ankylosing Spondylitis,
* Systemic Lupus Erythematosis.

In the DePaul Study of 1994 (unpublished), EPD was reportedly the highest ranked of all immune system /anti-viral therapies surveyed. When compared to over 50 current treatment programs it was ranked second highest as “enormous help” behind IV gamma globulin and ranked first over this treatment on an over-all rating. The De Paul study was conducted on patients with “MCS”, “Chronic Fatigue Syndrome”, “fibromyalgia”, and “electro-magnetic sensitivities” for which the patients had failed to get well with any previous form of treatment.

People who find relief from conventional treatments have no need to try the less-known EPD. EPD is likely to be used on the “hard” cases where other treatments have not been as succesful as desired. With the “hard case” factor not extrapolated into the results, the true results for the general population may even be better than the studies show.

« Prev12345Next »